Quantcast

Latest Rotavirus Stories

2008-10-03 09:00:38

Celldex Therapeutics, an integrated biopharmaceutical company, has received a milestone payment of $10 million from an affiliate of Paul Capital Healthcare. The payment was triggered by the market launch of Rotarix in the US. Rotarix is marketed worldwide by GlaxoSmithKline. John Leone, a partner at Paul Capital Healthcare, said: "In purchasing a portion of Celldex's Rotarix royalty stream, Paul Capital Healthcare has helped Celldex to monetize a previously under-appreciated asset. The...

2008-08-26 12:00:39

By JUDY SIEGEL-ITZKOVICH They're out there, and they're after us - viruses, bacteria and other pathogens that ignore personal and national boundaries. They spread not only by direct contact but also by plane or migrating birds. Infections with these pathogens are usually diagnosed too late - when victims already have symptoms, can't be treated effectively and have even infected others. In recent years, the phenomenon has threatened many parts of the world with a series of diseases...

2008-08-08 18:00:43

AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that Anthony S. Marucci, interim President and Chief Executive Officer of AVANT Immunotherapeutics, Inc., will present at the 28th Annual Canaccord Adams Global Growth Conference at the InterContinental Hotel in Boston on Wednesday, August 13 at 4:00 pm, EDT. A live webcast of the company presentation will be available in the Investor Information area of AVANT's website at http://www.avantimmune.com. An archive of the webcast...

2008-08-04 15:00:55

AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) will release its second quarter 2008 financial results before U.S. financial markets open on August 6, 2008. AVANT executives will host a conference call and live audio webcast at 9:00 am ET that same day. To access the live call, dial 888-713-4199 (within the United States) or 617-213-4861 (outside the United States). The passcode for participants is 98796339. A replay will be available approximately two hours after the live call. To access...

2008-06-30 06:02:50

Health benefits company WellPoint has announced that it will cover Rotarix, a rotavirus vaccine designed to prevent a virus which causes vomiting and diarrhea in infants and children. This decision to cover Rotarix, manufactured by GlaxoSmithKline, is based on formal recommendations announced by the US Centers for Disease Control and Prevention's advisory committee on Immunization Practices (ACIP). ACIP recommended that Rotarix be added to the list of recommended inoculations offered to...

2008-06-28 03:00:32

ATLANTA - A federal advisory panel has endorsed a second vaccine to combat a common and potentially fatal virus that causes diarrhea and vomiting in children. The new two-dose vaccine for infants, made by Glaxo-SmithKline, was licensed by the Food and Drug Administration in April. The vaccine advisory committee agreed Wednesday that it should be added to the recommended vaccines for infants, in addition to the three-dose vaccine made by Merck & Co. and approved in 2006. Both...

2008-06-27 12:03:10

INDIANAPOLIS, June 27 /PRNewswire/ -- WellPoint, Inc. announced today that, effective immediately, it will cover the rotavirus vaccine, Rotarix(R), designed to prevent a virus which causes vomiting and diarrhea in infants and children. This decision to cover Rotarix(R), manufactured by GlaxoSmithKline, is based on formal recommendations announced this week by the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP). ACIP recommended...

2008-06-26 12:03:21

ATLANTA and PHILADELPHIA, June 26 /PRNewswire-FirstCall/ -- Highlights Include: -- GSK's ROTARIX(R) [Rotavirus Vaccine, Live, Oral] recommended for routine vaccination of infants to protect against rotavirus gastroenteritis (RGE) -- ROTARIX, approved by the FDA on April 3, 2008, is the only rotavirus vaccine that offers completion of rotavirus immunization by four months of age in just two oral doses -- GSK's KINRIX(TM) [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed...

2008-06-25 15:01:53

Merck & Co., Inc., maker of ROTATEQ(R) (rotavirus vaccine, live, oral, pentavalent), is pleased that the U.S. Centers for Disease Control and Prevention's (CDC) report shows that rotavirus disease was dramatically reduced in the U.S. from November 2007 through May 2008 compared to previous years. Further monitoring and investigation are needed to assess whether the observed reduction in rotavirus disease reported by the CDC is related to the use of ROTATEQ(R). Data from two different...

2007-11-19 18:00:40

ATCC (American Type Culture Collection) announced today that its master cell bank of highly characterized Vero cells will be used for the manufacture of a second promising rotavirus vaccine candidate. The rotavirus vaccine candidate was developed by Murdoch Childrens Research Institute (MCRI) in Victoria, Australia. ATCC Vero cells will be used as substrates to grow the rotavirus strain that is being used in the vaccine. Several features make ATCC's Vero master cell bank a desirable...


Latest Rotavirus Reference Libraries

11_f79bc6a70a3ca6d0849bbfc3e310d871
2011-02-23 20:42:46

Rotavirus is the most common cause of diarrhea among infants and young children and is one of several viruses that cause the stomach flu. It is in the family Reoviridae and is a genus of double-stranded RNA. Most children have been infected by the age of five. Each infection builds on previous immunity and thus subsequent infections are less severe and adults are rarely affected. The fives species of the virus are referred to as A, B, C, D, and E. Type A, which is the most common, causes more...

More Articles (1 articles) »
Word of the Day
ween
  • To think; to imagine; to fancy.
  • To be of opinion; have the notion; think; imagine; suppose.
The word 'ween' comes from Middle English wene, from Old English wēn, wēna ("hope, weening, expectation"), from Proto-Germanic *wēniz, *wēnōn (“hope, expectation”), from Proto-Indo-European *wen- (“to strive, love, want, reach, win”).
Related